Search Results

Displaying 551 - 560 of 955

NINDS Interpretation of the NIH GDS Policy

… ON/AFTER Jan 25 2023 . ​​​​   Contact Your Program Officer Early to Discuss Data Sharing Expectations and Timelines … are encouraged to contact their Program Official as early as possible to discuss data sharing expectations and …

Jointly Sponsored Institutional Predoctoral Training Program (JSPTPN)

Purpose The NIH Jointly Sponsored Predoctoral Training Program in the Neurosciences (JSPTPN) is a multi-Institute effort that provides support for first- and second-year graduate students to obtain broad-based fundamental research training across the neuroscience spectrum. In addition to a broad education in fundamental neuroscience, the programs supported under this mechanism are expected to provide a strong foundation in experimental design, statistical methodology, quantitative literacy as well as strong oral and…

Jun Yin

… her journey at the National Institute of Neurological Disorders and Stroke ( NINDS ) in 2013 as a Research Fellow … neurodevelopmental diseases and neural degenerative disorders. Dr. Yin's research has delved into these areas, … transcriptome data associated with human neurological disorders to elucidate the functions of disease-related genes …

NIH Blueprint for Neuroscience Research

… of the brain and our approaches to treating brain disorders. Explore Blueprint’s scientific research areas … emerging modalities – for the treatment of nervous system disorders. The program supports investigator-led … as obesity, diabetes, anxiety, depression, substance use disorders, Alzheimer’s, Parkinson’s, autism, chronic pain, …

Rebecca Roof

Program Director Image Division of Translational Research Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Portfolio: Innovation Grants to Nurture Initial Translational Efforts (IGNITE). Early-stage…

Rose Cuento

… and has been with the National Institute of Neurological Disorders and Stroke (NINDS) since 2016, originally working …

Annette Gilchrist

Program Officer Image Division of Translational Research Small Business Innovation Research and Small Business Technology Transfer (SBIR/STTR) Portfolio: Small Business Innovation Research and Small Business Technology…

Saskia Hendriks

Neuroethics Consultant Image Office of Scientific Management and Operations Neuroethics, Bioethics Contact saskia.…

FDA Approval of Amyotrophic Lateral Sclerosis (ALS) Drug Represents Progress, But We’re Not Done

… families and caregivers. Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that … Food and Drug Administration (FDA) approved Relyvrio for ALS. Relyvrio is a combination of two drugs, sodium … joins Riluzole and Edaravone as therapeutic options for ALS patients. These options may slow disease progression and …

Parkinson’s Disease Awareness Month: NINDS Contributions to Research and Potential Treatments

Thursday, April 27, 2023 April is Parkinson’s Disease Awareness Month, chosen because it is the birth month of James Parkinson, who first identified the symptoms of Parkinson’s disease more than 200 years ago. Since then, we have made considerable progress towards understanding what causes the motor symptoms we most associate with Parkinson’s…